Start from a real enquiry
Review your website, ad forms or CRM as possible sources. Trigger contact only through a reliable, permitted connection.
Speed-to-Lead AI Agent
Follow up on a new clinic enquiry while the conversation is still relevant. Capture intent, answer approved questions and arrange the next step.
Map your enquiry response Explore the scopeWebsite / lead form
Contact permission + contextStart the
conversation.
The difference
A new treatment enquiry can sit unanswered while the front desk handles patients. By the time someone follows up, the person may have moved on.
New leads sit in an inbox
An agreed trigger starts a timely contact attempt.
Your team repeats the same intake questions
Approved questions capture the reason, preferences and next step.
Follow-up happens without a clear owner
The outcome and any unresolved question go to your team.
A workflow comparison, not a measured customer result.
What we build with you
Review your website, ad forms or CRM as possible sources. Trigger contact only through a reliable, permitted connection.
Capture interest, location and appointment preferences using approved wording. Clinical suitability is assessed by your clinic, not the agent.
Use a supported booking route or pass a clear request to a person. Do not invent availability or confirm an unverified slot.
Agree contact windows, attempt limits, opt-outs and the point where a person takes over. Log the outcome where supported.
From conversation to scope
Map the source and contact permissions.
Agree the conversation, booking route and limits.
Test answered, unanswered and exception scenarios.
No. The receptionist handles inbound calls. Speed-to-Lead follows up on a submitted enquiry through the agreed contact route. They can share context when that connection is included.
No. It captures administrative intent and preferences. Treatment recommendations, medical questions and suitability go to your clinic.
Related guide: The Five-Minute Lead Response Rule and Its Limits
Start with the work, not the software.